Chicago, IL – According to filings with the U.S. Securities and Exchange Commission, Dimension Inx is raising $3,385,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Caralynn Collens played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Dimension Inx

Dimension Inx is an emerging leader in biofabrication, the next frontier in medicine. Our 3D-Painting Materials Design and Manufacturing System offers the versatility, manufacturability, and affordability necessary for widespread adoption of tissue-engineered regenerative medical products. We are creating biomaterials and 3D-printed implants that fundamentally change how we treat human disease and debilitation. We are developing a new class of treatments that dramatically improves the standard of care and addresses the shortage of donor tissues and organs.

To learn more about Dimension Inx, visit http://www.dimensioninx.com/

Contact:
Caralynn Collens, President and Chief Executive Officer
312-235-3510
https://www.linkedin.com/in/caralynnnowinski/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved